TrialX
Image

Vienna Versus SARS-CoV-2 Virus Study

Vienna Versus SARS-CoV-2 Virus Study

Recruiting
100 years and younger
All
Phase N/A

Overview

This study examines the seroprevalence against SARS-CoV-2 in health care workers and patients at the Vienna General Hospital.

Description

This study consists of 2 parts: a longitudinal study enrolling 3,000 health care professionals at the Vienna General Hospital testing their antibody status 6 times over a period of 12 months (Cohort A), and a serial cross-sectional study of 3,000 patients (i.e., a total of 9,000 patients) admitted to the Vienna General Hospital for non-COVID-19-related symptoms at 3 different time points during this pandemic (Cohort B).

Eligibility

Cohort A:

Inclusion criteria:

  • Physicians
  • Nursing staff
  • Midwives
  • Medical-technical assistants (including medical, therapeutic and diagnostic healthcare staff, and medical and nursing assistants)
  • Administrative personnel with patient contact

Exclusion Criteria:

  • Not employed at the Medical University of Vienna or the Vienna General Hospital
  • No signed informed consent

Cohort B:

Inclusion Criteria:

Patients with available residual serum samples

Exclusion Criteria:

Serum samples from COVID-19 triage units at the Vienna General Hospital

Study details
    Covid 19
    SARS-CoV-2

NCT04407429

Medical University of Vienna

1 February 2023

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.